Natural Allelic Variations in Glutathione Peroxidase-1 Affect Its Subcellular Localization and Function
journal contributionposted on 2016-04-12, 00:00 authored by Soumen Bera, Frank Weinberg, Dede N. Ekoue, Kristine Ansenberger-Fricano, Mao Mao, Marcelo G. Bonini, Alan M. Diamond
Glutathione peroxidase 1 (GPx-1) has been implicated in the etiology of several common diseases due to the association between specific allelic variations and cancer risk. The most common among these variations are the codon 198 polymorphism that results in either a leucine or proline and the number of alanine repeat codons in the coding sequence. The molecular and biological consequences of these variations remain to be characterized. Towards achieving this goal, we have examined the cellular location of GPx-1 encoded by allelic variants by ectopically expressing these genes in MCF-7 human breast carcinoma cells that produce undetectable levels of GPx-1, thus achieving exclusive expression in the same cellular environment. A differential distribution between the cytoplasm and mitochondria was observed, with the allele expressing the leucine-198 polymorphism and 7 alanine repeats being more cytoplasmically located than the other alleles examined. To assess whether the distribution of GPx-1 between the cytoplasm and mitochondria had a biological consequence, we engineered derivative GPx-1 proteins that were targeted to the mitochondria by the addition of a mitochondria targeting sequence and expressed these proteins in MCF-7 cells. These cells were examined for their response to oxidative stress, energy metabolism and impact on cancer-associated signaling molecules. The results obtained indicated that both primary GPx-1 sequence and cellular location have a profound impact on cellular biology and offer feasible hypotheses as to how expression of distinct GPx-1 alleles can impact cancer risk.
This work was supported by a grant from the National Institutes of Health [Grant # RO1CA127943] to AMD, a Post Doctoral Fellowship from the American Institute for Cancer Research [Grant #10A072] to SB and by a grant from the Department of Defense W911NF-07-R-0003-04 to MB
PublisherAmerican Association for Cancer Research